Erika Marie Adkins - Publications

Affiliations: 
2001 Vanderbilt University, Nashville, TN 

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Henry LK, Field JR, Adkins EM, Parnas ML, Vaughan RA, Zou MF, Newman AH, Blakely RD. Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants. The Journal of Biological Chemistry. 281: 2012-23. PMID 16272152 DOI: 10.1074/Jbc.M505055200  0.607
2003 Rasmussen SG, Adkins EM, Carroll FI, Maresch MJ, Gether U. Structural and functional probing of the biogenic amine transporters by fluorescence spectroscopy. European Journal of Pharmacology. 479: 13-22. PMID 14612134 DOI: 10.1016/J.Ejphar.2003.08.053  0.441
2003 Henry LK, Adkins EM, Han Q, Blakely RD. Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. The Journal of Biological Chemistry. 278: 37052-63. PMID 12869570 DOI: 10.1074/Jbc.M305514200  0.696
2002 Rosenthal SJ, Tomlinson I, Adkins EM, Schroeter S, Adams S, Swafford L, McBride J, Wang Y, DeFelice LJ, Blakely RD. Targeting cell surface receptors with ligand-conjugated nanocrystals. Journal of the American Chemical Society. 124: 4586-94. PMID 11971705 DOI: 10.1021/Ja003486S  0.639
2001 Adkins EM, Barker EL, Blakely RD. Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Molecular Pharmacology. 59: 514-23. PMID 11179447 DOI: 10.1124/Mol.59.3.514  0.718
1998 Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, Blakely RD. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. The Journal of Biological Chemistry. 273: 19459-68. PMID 9677366 DOI: 10.1074/Jbc.273.31.19459  0.727
Show low-probability matches.